Viking Therapeutics (VKTX) stock has been on a rollercoaster ride, dropping by 10.9% on a recent Monday afternoon. This dip comes after significant company updates in February, such as meeting Phase 2 VENTURE trial goals and a public offering of common shares at $85 each.
When considering whether VKTX is a worthwhile investment, factors like valuation, price movements, and capital allocation strategies come into play. While Viking Therapeutics doesn’t offer dividends, they can still create value for shareholders through various methods. Recently, the company implemented a buyback initiative, which could help boost share prices by boosting demand.
On March 10, 2022, Viking Therapeutics’ Board of Directors approved a buyback program. Between April 1, 2022, and June 30, 2022, the company repurchased over 700,000 shares for $1.66 million. Furthermore, in March 2020, Viking Therapeutics unveiled a buyback plan totaling up to $50 million over two years.
These buyback schemes can impact investor confidence and stock prices by showcasing faith in the company’s worth and potentially providing a safety net for share values.
VKTX Stock Plummets 11.79% on March 11, 2024: Analysis and Outlook
On March 11, 2024, VKTX stock experienced a significant drop in its price performance. According to data from CNN Money, the stock opened at $69.94, which was $1.84 lower than its previous close. Throughout the trading day, the price of VKTX shares continued to decline, ultimately dropping by $8.46, or 11.79%.
Despite this sharp decrease in price, VKTX is still trading in the middle of its 52-week range and is currently above its 200-day simple moving average. This suggests that while the stock may have experienced a short-term decline, it is still performing relatively well compared to its historical performance and long-term trend.
VKTX Stock Performance Analysis: Net Income and EPS Trends – March 11, 2024
On March 11, 2024, VKTX stock showed mixed performances based on the financial data available. The company’s net income for the past year was reported at -$85.89 million, with a decrease of 24.73% compared to the previous year. In the last quarter, VKTX’s net income was -$24.61 million, showing a slight increase of 0.0% compared to the previous quarter.
Similarly, the earnings per share (EPS) for VKTX were reported at -$0.91 for the past year, reflecting a 1.57% increase compared to the previous year. In the last quarter, the EPS was reported at -$0.25, showing no change compared to the previous quarter.
Investors and analysts may want to closely monitor VKTX’s financial reports and any updates on its total revenue to gain a better understanding of the company’s overall financial health and future prospects. As with any investment, it is important to conduct thorough research and analysis before making any decisions regarding VKTX stock.
